Accounts Payable, Current of TEVA PHARMACEUTICAL INDUSTRIES LTD from 31 Dec 2023 to 31 Dec 2025

Taxonomy & unit: us-gaap: USD
Description: Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Summary: TEVA PHARMACEUTICAL INDUSTRIES LTD quarterly Accounts Payable, Current in USD history and change rate from 31 Dec 2023 to 31 Dec 2025.
TEVA PHARMACEUTICAL INDUSTRIES LTD Accounts Payable, Current for the quarter ending 31 Dec 2025 was $225,000,000, a 42% increase year-over-year.
Source SEC data: View on sec.gov

Accounts Payable, Current, Quarterly (USD)

Accounts Payable, Current, YoY Quarterly Change (%)

TEVA PHARMACEUTICAL INDUSTRIES LTD Quarterly Accounts Payable, Current (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2025	$225,000,000	+$67,000,000	+42%	31 Dec 2025	10-K	03 Feb 2026	2025	FY
Q4 2024	$158,000,000	+$50,000,000	+46%	31 Dec 2024	10-K	03 Feb 2026	2025	FY
Q4 2023	$108,000,000			31 Dec 2023	10-K	03 Feb 2026	2025	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.